| HUBB |
Report |
Adj. Operating Margin (Q2 2026) |
BEAT |
pred ~24.5% vs. cons 24.11% |
MEDIUM |
| HUBB |
Report |
Total Organic Growth (Q2 2026) |
IN-LINE |
pred ~9.5% vs. cons ~8.8% |
MEDIUM |
| HUBB |
Report |
Adj. EPS Diluted (Q2 2026) |
BEAT |
pred ~$5.52 vs. cons $5.38 |
MEDIUM |
| HUBB |
Guide |
FY 2026 Organic Growth (FY) |
BETTER |
guide ~8.5% midpoint vs. cons ~8.1% |
MEDIUM |
| HUBB |
Guide |
FY 2026 Adj. EPS (FY) |
UNCHANGED |
guide ~$19.85 midpoint vs. cons $19.84 |
MEDIUM |
| HUBB |
Guide |
FY 2026 Adj. Op. Margin (FY) |
UNCHANGED |
guide ~23.0% vs. cons 23.03% |
MEDIUM |
| HUBB |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
MEDIUM |
| HUBB |
Return |
5-day cumulative residual |
+3.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — sell-side H2 EPS revisions driven by FY organic raise and implied H2 math (+7% above Street); partially offset by pre-print run already consuming some upside |
MEDIUM |